Butenafine Hydrochloride

盐酸布替萘芬

Report date: 2026/04/03 17:35:46
NME

Base Information

Drug NameButenafine Hydrochloride
Drug Alias NameLotrimin Ultra盐酸布替那芬盐酸布蝶呐Funcid盐酸丁萘芬 +[20] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSqualene monooxygenase inhibitors
TargetsSqualene monooxygenase
Therapy Area/IndicationsTinea CrurisHypersensitivityPruritus +[9] 
Global Approved IndicationsTinea CrurisSkin Diseases, InfectiousTinea Versicolor +[5] 
Approved Indications in ChinaSkin Diseases, Infectious
Original Approved Country/TerritoryJapan
Original Approved Date1992/04/17
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co LtdBayer Healthcare Pharmaceuticals LlcSichuan Med-Shine Pharmaceutical Co Ltd
Inactive CompaniesPharmobedient Consulting LLCBayer AGTaro Pharmaceuticals Usa Inc
Active IndicationsTinea CrurisPruritusSkin Diseases, Infectious +[6] 
Inactive IndicationsHypersensitivityDermatitis, PhototoxicDermatitis, Photoallergic

Other Information

ATC CodeD01AE23
Related LinksWikipediaDrugBankKEGG